Other languages Surmodics, Inc.

Equities

SRDX

US8688731004

Real-time Estimate Cboe BZX Other stock markets 03:12:07 2024-04-29 pm EDT			5-day change	1st Jan Change
26.08 ^USD	-0.36%		+2.52%	-28.39%

Feb. 06	Barrington Trims Price Target on SurModics to $70 From $71, Keeps Outperform Rating	MT
Feb. 01	Needham Adjusts SurModics' Price Target to $47 From $44, Maintains Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Surmodics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 01
Surmodics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Feb. 01
Surmodics, Inc. Announces Successful Early Clinical Use of its Pounce LP Thrombectomy System	Jan. 22
Surmodics, Inc. Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium	Nov. 16
Surmodics, Inc. Announces 24-Month Data from the Swing Trial Presented At VEITHsymposium	Nov. 16
Surmodics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Nov. 08
Surmodics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Nov. 08
Surmodics, Inc. Provides Earnings Guidance for the Year 2024	Nov. 08
Surmodics, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Nov. 08
Surmodics, Inc. Announces Swing Trial 24-Month Data to Be Presented At Veith Symposium on November 15	Nov. 07
Surmodics, Inc. Announces Launch of Preside Medical Device Coating Technology, Providing Lubricity and Durability to a Broader Range of Complex Device Applications	23-10-31
Surmodics, Inc. Revises Earnings Guidance for the Fiscal Year Ending September 30, 2023	23-08-02
Surmodics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-02
SurModics Receives FDA Approval for the SurVeil Drug-Coated Balloon	23-06-20
Surmodics, Inc. Receives FDA Approval for the SurVeil Drug-Coated Balloon	23-06-20
Surmodics Says US FDA's 510(k) Clearance Received for Low-Profile Thrombectomy System	23-06-14
Surmodics Receives FDA 510(k) Clearance for Pounce LP Thrombectomy System	23-06-14
Surmodics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-04-26
Surmodics, Inc. Revises Earnings Guidance for the Fiscal Year 2023	23-04-26
Surmodics Says First Patient Enrolled in PROWL Registry Study	23-04-20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Surmodics, Inc.

Equities

SRDX

US8688731004

Other languages

Filters